| Date | Company Name | Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|---|
| Sep 12, 2022 | Nimbus Therapeutics | Series Unknown | — | Biotechnology | — |
| Apr 15, 2021 | Alchemab Therapeutics | Series A | — | Biotechnology | — |
| Apr 26, 2017 | Arsanis | Series D | — | Biotechnology | — |
| Dec 30, 2016 | Good Start Genetics | Debt Financing | — | Biotechnology | — |
| Jul 29, 2016 | Good Start Genetics | Debt Financing | — | Biotechnology | — |
| Apr 27, 2016 | Arsanis | Series C | — | Biotechnology | Yes |
| Apr 12, 2016 | Arsanis | Debt Financing | — | Biotechnology | — |
| Apr 4, 2016 | Good Start Genetics | Debt Financing | — | Biotechnology | — |
| Jul 22, 2015 | KalVista Pharmaceuticals | Series B | — | Biotechnology | — |
| Jan 1, 2014 | X4 Pharmaceuticals | Seed | — | Biotechnology | — |
| Nov 14, 2013 | Astria Therapeutics | Series B | — | Biopharma | — |
| Sep 3, 2013 | Arsanis | Series B | — | Biotechnology | — |
| Feb 6, 2013 | Astria Therapeutics | Series Unknown | — | Biopharma | — |
| Apr 2, 2012 | Good Start Genetics | Series B | — | Biotechnology | — |
| Dec 13, 2011 | Astria Therapeutics | Series A | — | Biopharma | — |
| Aug 23, 2011 | KalVista Pharmaceuticals | Series A | — | Biotechnology | Yes |
| Feb 28, 2011 | Arsanis | Series A | — | Biotechnology | Yes |
| Dec 8, 2010 | Astria Therapeutics | Series A | — | Biopharma | Yes |
| Sep 10, 2010 | Good Start Genetics | Series A | — | Biotechnology | Yes |
| Apr 21, 2010 | Astria Therapeutics | Series A | — | Biopharma | Yes |
| Dec 15, 2009 | IVERIC bio | Series B | — | Biotechnology | — |
| Aug 13, 2007 | IVERIC bio | Series A | — | Biotechnology | Yes |